Long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: 4-year results from the expanded access program.
Jerzy P SzaflarskiOrrin DevinskyMerrick LopezYong D ParkPilar Pichon ZentilAnup D PatelElizabeth A ThieleRobert T WechslerDaniel CheckettsFarhad SahebkarPublished in: Epilepsia (2022)
Add-on CBD was associated with sustained seizure reduction up to 192 weeks with an acceptable safety profile and can be used for long-term treatment of TREs.